| Literature DB >> 26217810 |
Marta Martin-Lorenzo1, Benjamin Balluff2, Aroa S Maroto1, Ricardo J Carreira2, Rene J M van Zeijl2, Laura Gonzalez-Calero1, Fernando de la Cuesta3, Maria G Barderas3, Luis F Lopez-Almodovar4, Luis R Padial5, Liam A McDonnell2, Fernando Vivanco6, Gloria Alvarez-Llamas1.
Abstract
Subclinical atherosclerosis cannot be predicted and novel therapeutic targets are needed. The molecular anatomy of healthy and atherosclerotic tissue is pursued to identify ongoing molecular changes in atherosclerosis development. Mass Spectrometry Imaging (MSI) accounts with the unique advantage of analyzing proteins and metabolites (lipids) while preserving their original localization; thus two dimensional maps can be obtained. Main molecular alterations were investigated in a rabbit model in response to early development of atherosclerosis. Aortic arterial layers (intima and media) and calcified regions were investigated in detail by MALDI-MSI and proteins and lipids specifically defining those areas of interest were identified. These data further complement main findings previously published in J Proteomics (M. Martin-Lorenzo et al., J. Proteomics. (In press); M. Martin-Lorenzo et al., J. Proteomics 108 (2014) 465-468.) [1,2].Entities:
Year: 2015 PMID: 26217810 PMCID: PMC4510571 DOI: 10.1016/j.dib.2015.06.005
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Representative MALDI-MSI images for proteins (A) and lipids (B, C) in rabbit aorta. Intima (I) and media (M) layers and calcified regions (P) in the intima are defined by specific m/z values. Characterization of samples is made according to histology: H&E, Oil-Red (OR) and Red Alizarin (RA).
MALDI-MSI m/z values with specific localization in the intima or media layer are shown (left column): xp means specifically located in the calcified region of the intima layer. Comparison between healthy and atherosclerotic tissues is also included (right column):↑increased in atherosclerosis;↓decreased in atherosclerosis; P: pathologic (atherosclerotic) tissue; C: control (healthy) tissue. Bold numbers show statistical significance (p Value <0.05, Mann–Whitney test). Identification was performed by FT-ICR measurements, MaTisse database, MSiMass list database and literature [12,13].
| x | ↑ | 1.67 | SEL1L, IQGAP1, GANAB, NCSTN, UGDH, CYBA, YWHAG, MIF, EIF2S3, SYNM, ITGA5, NDUFS7, COL12A1, VASN, EEF1A1, MYBPC1, HBA1-2, ENO1, UBA1, CA3, MUC5B | ||||
| x | ↓ | 0.64 | NSF, PSMC4, ACTB, MYL2, PKM2, HSPD1 | ||||
| x | ↓ | 0.67 | DHRS7, ACTB, MYL2, PKM2, ERP44, S100A6 | ||||
| x | ↓ | 0.92 | 0.4589 | – | |||
| x | ↓ | 0.93 | 0.6494 | HBB | |||
| x | ↑ | 3.00 | TMSB4X | ||||
| x | ↑ | 2.07 | – | ||||
| x | ↓ | 0.58 | – | ||||
| x | ↓ | 0.49 | – | ||||
| x | ↓ | 0.57 | – | ||||
| x | ↑ | 4.98 | SFA | ||||
| x | ↑ | 8.74 | Lysolipids | ||||
| x | ↑ | 4.58 | Lysolipids | ||||
| x | ↑ | 5.64 | LPC (0:0/18:1), lysolipids | ||||
| xP | ↑ | 4.21 | – | ||||
| xP | 0.3524 | ↑ | 1.42 | 0.1714 | – | ||
| xP | 0.1714 | ↑ | 3.57 | 0.0667 | – | ||
| xP | 0.0667 | ↑ | 6.84 | PA | |||
| xP | 0.1143 | ↑ | 4.61 | PA+PG | |||
| xP | 0.0667 | ↑ | 4.43 | SM+PA+PE−Cer | |||
| xP | 0.1143 | ↑ | 4.76 | 0.1143 | PC+PE | ||
| x | ↑ | 3.74 | SM | ||||
| x | ↑ | 9.77 | PG | ||||
| x | ↑ | 6.54 | PI | ||||
| x | ↑ | 1.03 | PC | ||||
| x | 0.0931 | ↑ | 6.52 | Glc−GP+PI | |||
| x | ↑ | 6.18 | PS | ||||
| xP | 0.3874 | ↑ | 1.51 | 0.1320 | TG | ||
| Subject area | Biology |
| More specific subject area | Cardiovascular disease, MSI development and application to arterial tissue |
| Type of data | Table and figure |
| How data was acquired | MALDI-MSI, FTICR |
| Data format | Analyzed |
| Experimental factors | Specific and careful tissue treatment was applied as previously published |
| Experimental features | |
| Data source location | LUMC (Leiden, The Netherlands), IIS-Fundación Jiménez Díaz (Madrid, Spain) |
| Data accessibility |